Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19.
Bai X, Buckle AM, Vladar EK, Janoff EN, Khare R, Ordway D, Beckham D, Fornis LB, Majluf-Cruz A, Fugit RV, Freed BM, Kim S, Sandhaus RA, Chan ED.
Bai X, et al. Among authors: khare r.
Sci Rep. 2022 Mar 25;12(1):5207. doi: 10.1038/s41598-022-09133-9.
Sci Rep. 2022.
PMID: 35338216
Free PMC article.